American Renal Associates Holdings, Inc
ARA
ARA was delisted on the 25th of January, 2021.
82 hedge funds and large institutions have $357M invested in American Renal Associates Holdings, Inc in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 27 reducing their positions, and 10 closing their positions.
4% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 27
0% more funds holding
Funds holding: 82 → 82 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
46% less capital invested
Capital invested by funds: $665M → $357M (-$308M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Foresters Investment Management
New York
|
+$5.66M |
| 2 |
VBA
Van Berkom & Associates
Montreal,
Quebec, Canada
|
+$4.52M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$2.81M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$1.89M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$9.12M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$2.14M |
| 3 |
Millennium Management
New York
|
-$1.7M |
| 4 |
Two Sigma Investments
New York
|
-$1.08M |
| 5 |
Barclays
London,
United Kingdom
|
-$952K |
ARA Hedge Fund Activity: Q4 2018 in Review
82 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q4 2018, worth a combined $357M — down 46% from $665M a quarter earlier.
Fund positioning in ARA was balanced in Q4 2018: 10 funds opened new positions, 10 closed out, 28 added to existing stakes and 27 trimmed.
The largest buyer was Foresters Investment Management, opening a new position worth an estimated $5.66M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $9.12M sold.
- 82 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $357M of American Renal Associates Holdings, Inc stock for Q4 2018, down 46% quarter-over-quarter.
- 10 funds opened new American Renal Associates Holdings, Inc positions in Q4 2018 and 10 closed out, a net change of 0 holders.
- The largest American Renal Associates Holdings, Inc buyer in Q4 2018 was Foresters Investment Management, an estimated $5.66M added.
- The largest American Renal Associates Holdings, Inc seller in Q4 2018 was OppenheimerFunds, an estimated $9.12M sold.
Based on aggregated 13F filings for Q4 2018.